The level of myeloid derived-suppressor cells in peripheral blood of patients with prostate cancerafter various types of therapy.

In conclusion, we suggest that Mo-MDSC should be considered as a potential therapy target in the course of prostate cancer treatment to enhance its anti-tumor effectiveness. PMID: 32429654 [PubMed - in process]
Source: Polish Journal of Pathology - Category: Pathology Tags: Pol J Pathol Source Type: research